Atlas Trials

Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)

Clinical trial NCT02179931 · COMPLETED

Trial details

NCT number
NCT02179931
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Men and Women
Start date
2014-06-01
Primary completion
2014-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.